Analyst Recommendations

UBS analyst issues NEUTRAL recommendation for AXP on April 4, 2024 12:14PM ET. The previous analyst recommendation was Neutral.AXP was trading at $226.85 at issue of the analyst...

April 4, 2024   AXP 2.64%

UBS analyst issues NEUTRAL recommendation for SYF on April 4, 2024 12:15PM ET. The previous analyst recommendation was Neutral.SYF was trading at $41.95 at issue of the analyst...

April 4, 2024   SYF 3.28%

Raymond James analyst issues UNDERPERFORM recommendation for CVS on April 4, 2024 11:00AM ET. The previous analyst recommendation was Underperform.CVS was trading at $75.025 at issue of the...

April 4, 2024   CVS 2.62%

Wells Fargo analyst issues EQUAL-WEIGHT recommendation for KKR on April 4, 2024 11:00AM ET. The previous analyst recommendation was Equal-Weight.KKR was trading at $100.76 at issue of the...

April 4, 2024   KKR 3.72%

Morgan Stanley analyst issues UNDERPERFORM recommendation for KKR on April 4, 2024 11:00AM ET. The previous analyst recommendation was Underperform.KKR was trading at $100.76 at issue of the...

April 4, 2024   KKR 3.72%

Stephens analyst issues BUY recommendation for UNH on April 4, 2024 11:00AM ET. The previous analyst recommendation was Buy.UNH was trading at $459.75 at issue of the analyst...

April 4, 2024   UNH 2.71%

RBC Capital analyst issues UNDERPERFORM recommendation for UNH on April 4, 2024 11:00AM ET. The previous analyst recommendation was Underperform.UNH was trading at $459.75 at issue of the...

April 4, 2024   UNH 2.71%

RBC Capital analyst issues EQUAL-WEIGHT recommendation for CVS on April 4, 2024 11:00AM ET. The previous analyst recommendation was Equal-Weight.CVS was trading at $75.025 at issue of the...

April 4, 2024   CVS 2.62%

Scotiabank analyst issues SECTOR PERFORM recommendation for DRETF on April 4, 2024 11:22AM ET. The previous analyst recommendation was Sector Perform.DRETF was trading at $5.9723 at issue of...

April 4, 2024   CVS 2.62%

CIBC analyst issues OUTPERFORM recommendation for RCI on April 4, 2024 11:08AM ET. The previous analyst recommendation was Outperform.RCI was trading at $39.76 at issue of the analyst...

April 4, 2024   RCI 1.48%